Related Experiment Video
Updated: Jan 7, 2026

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
Published on: June 2, 2023
Coupling Mitochondrial Homeostasis to Oxi-Inflamm-Aging Network Disruption via Peptide-Functionalized Nanocomposite
Zhao Zhang1, Xiaohe Wang1, Pengyu Fan2
1Department of Orthopaedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
Abstract:
Osteoarthritis(OA) is an age-related degenerative joint disease, and the absence of clinically effective therapy places a substantial burden on global health. The crosstalk among oxidation, inflammation, and aging (oxi-inflamm-aging) disrupts chondrocytes homeostasis, serving as a critical driver in OA initiation and progression. Here, we developed a mitochondria-centered therapeutic strategy aimed at concomitantly disrupting the pathogenic oxi-inflamm-aging network. This strategy emphasized a novel chimeric peptide (MW) designed by integrating the mitochondrial protective MOTS-s and cartilage-targeting WYRGRL. To enhance therapeutic delivery and efficacy, the bifunctional chimeric peptide MW is immobilized onto GeSe nanosheets, which are then embedded within a multifunctional responsive hydrogel composed of HA-MAL, MMP13-sensitive peptide, and PF127 (HMP), forming the peptide-functionalized nanocomposite hydrogel (MW@GeSe@HMP). This engineered nanocomposite hydrogel not only exhibited efficient enzyme-mimicking mimetic properties to scavenge harmful oxygen radicals, but also enabled MMP-responsive targeted release in chondrocytes. Subsequent biological experiments revealed that MW@GeSe@HMP effectively disrupted the oxi-inflamm-aging network by modulating mitochondrial function, thereby maintaining chondrocyte homeostasis. Mechanistically, MW@GeSe@HMP protected chondrocytes via hindering cGAS/STING signaling. The nanocomposite hydrogel also significantly suppressed cartilage damage and matrix degradation, effectively alleviating OA progression in a rat OA model. In conclusion, this study developed a nanocomposite hydrogel integrating bioactive peptides and two-dimensional nanoenzyme, providing a prospective therapeutic strategy and potential target for OA treatment by regulating oxi-inflamm-aging integrative network.
Insights
A novel nanocomposite hydrogel targets osteoarthritis by disrupting oxidation, inflammation, and aging. This mitochondria-centered therapy protects chondrocytes and alleviates joint damage in a rat model.
Area of Science:
- Biomaterials Science
- Nanomedicine
- Osteoarthritis Research
Background:
- Osteoarthritis (OA) is a major global health burden driven by the interplay of oxidation, inflammation, and aging (oxi-inflamm-aging), disrupting chondrocyte homeostasis.
- Current OA therapies lack clinical efficacy, necessitating innovative treatment strategies.
Purpose of the Study:
- To develop a mitochondria-centered therapeutic strategy to disrupt the pathogenic oxi-inflamm-aging network in OA.
- To engineer a peptide-functionalized nanocomposite hydrogel for enhanced OA treatment.
Main Methods:
- A novel chimeric peptide (MW) integrating mitochondrial protection (MOTS-s) and cartilage targeting (WYRGRL) was synthesized.
- The MW peptide was immobilized onto GeSe nanosheets and embedded in a responsive hydrogel (HMP) to form MW@GeSe@HMP.
- In vitro and in vivo OA models were used to evaluate the hydrogel's efficacy in scavenging radicals, targeted release, chondrocyte protection, and OA alleviation.
Main Results:
- The MW@GeSe@HMP hydrogel demonstrated enzyme-mimicking properties for radical scavenging and MMP-responsive release in chondrocytes.
- The hydrogel effectively disrupted the oxi-inflamm-aging network, modulated mitochondrial function, and maintained chondrocyte homeostasis.
- MW@GeSe@HMP protected chondrocytes by inhibiting cGAS/STING signaling, suppressed cartilage damage, and alleviated OA progression in a rat model.
Conclusions:
- A peptide-functionalized nanocomposite hydrogel (MW@GeSe@HMP) was successfully developed for OA treatment.
- This strategy offers a prospective therapeutic approach by regulating the oxi-inflamm-aging network and targeting mitochondrial dysfunction.
- The study highlights a potential new therapeutic target for OA by addressing the integrated pathological pathways.
More Related Videos
06:26Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
Published on: January 24, 2025
15:33Microwave-assisted Functionalization of Polyethylene glycol and On-resin Peptides for Use in Chain Polymerizations and Hydrogel Formation
Published on: October 29, 2013
Related Concept Videos
Mitochondria
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
The Effect of Aging on Tissues